SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-332717
Filing Date
2013-08-13
Accepted
2013-08-13 16:13:22
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d548373d10q.htm 10-Q 696945
2 EX-4.18 d548373dex418.htm EX-4.18 45062
3 EX-31.1 d548373dex311.htm EX-31.1 5999
4 EX-31.2 d548373dex312.htm EX-31.2 5967
5 EX-32.1 d548373dex321.htm EX-32.1 3068
6 EX-32.2 d548373dex322.htm EX-32.2 3023
  Complete submission text file 0001193125-13-332717.txt   6265683

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ambi-20130630.xml EX-101.INS 687106
8 XBRL TAXONOMY EXTENSION SCHEMA ambi-20130630.xsd EX-101.SCH 41749
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ambi-20130630_cal.xml EX-101.CAL 45913
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ambi-20130630_def.xml EX-101.DEF 121204
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ambi-20130630_lab.xml EX-101.LAB 317952
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ambi-20130630_pre.xml EX-101.PRE 208419
Mailing Address 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address 11080 ROSELLE STREET SAN DIEGO CA 92121 8583342100
AMBIT BIOSCIENCES CORP (Filer) CIK: 0001131543 (see all company filings)

IRS No.: 330909648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35919 | Film No.: 131033262
SIC: 2834 Pharmaceutical Preparations